Vernessa T. Pollard is a Partner in the Health Care Practice Group of the International law fi rm of McDermott Will & Emery LLP. Based in Washington DC, she is co-chair of the Firm’s Food Drug and Administration (FDA) practice.
Vernessa provides strategic business and regulatory advice to biotech, medical device companies on complex issues related to the development, manufacture, marketing, post-market safety and compliance of FDA-regulated products, including digital health and mobile devices. She counsels companies on product development and premarket strategy, good manufacturing practice and quality system requirements, advertising and promotion, adverse event reporting, FDA warning letters, FDA inspections, recalls, import detentions, corporate compliance programs and regulatory due diligence in mergers and acquisitions.
As a former Associate Chief Counsel for Enforcement in FDA’s Office of Chief Counsel, Vernessa handled enforcement, compliance and regulatory matters on behalf of the FDA. Vernessa is passionate about working with life sciences companies because what they do and how they do it has the potential to change lives and improve healthcare in remarkable ways. Vernessa has been recognized in numerous Law and Life Sciences publications, to include Chambers USA 2014 to 2017.
